Review of JP Morgan Conference
January 29 @ 11am – 2pm ET
Share:
RSVP to attend
Speakers
Agenda
11:00 AM
Session
Gil Bashe, Chair Global Health & Purpose, FINN Partners
11:15 AM
What JPM Reveals About the Next Healthcare Investment Cycle
Bill Taranto, President, Merck GHI
11:30 AM
From JPM to the Nursery: The Future of Women’s & Infant Health
Shaker Rawan, Founder & CEO, Woddle
11:45 AM
Modern Clinical Trials: What Works, What Breaks, What’s Next
Harsha K. Rajasimha, CEO and Founder, Jeeva Clinical Trials Inc
12:00 PM
Beyond SBIRs: NIH as a Technology Commercialization Partner
Michael Salgaller, Supervisory Technology Analysis and Marketing Specialist, The National Institutes of Health
12:15 PM
What ChatGPT Means for the Next Era of Healthcare
Christopher H. Reitz, Senior Director, Enterprise AI, Elevance Health
The Next Chapter of Women's Health
Divya Verma, Vice President of Business Development @ Accord Healthcare US. & Chair of HITLAB’s Women’s Health Tech Initiative
AI & Mental Health After JPM: What 2026 Demands Next
Mike Meaney, CEO, One Small Step
Operationalizing AI: Lessons from the Front Lines
Pervej Alam, Co Founder/ CEO, PulpDigital.ai
Session
Mathew Kittay, Partner, Co‑Chair, Mergers & Acquisitions, Fox Rothschild LLP
Session
Ainsley MacLean, General Partner, Ainsley & Born Capital
Want to speak, sponsor, or participate more in our events?